6 health tech startups at IIT-B to receive upto Rs 6 Cr cumulative seed funding
January 12, 2026 | Monday | News
Each startup to receive funding support of up to Rs 1 crore, subject to evaluation outcomes
image credit- freepik
The Technology Innovation Hub (TIH) at the Indian Institute of Technology (IIT) Bombay under the Department of Science and Technology (DST), Govt of India successfully concluded ATMAN 3.0, its eight-week accelerator programme designed to transform early-stage HealthTech startups into investment-ready businesses.
The programme culminated in a Demo Day bringing together investors, healthcare leaders, industry experts, and policymakers to engage with some of the most promising healthcare innovations in the country.
ATMAN 3.0 saw strong participation from across India, with 173 HealthTech startups pitching their ideas to TIH IIT Bombay. Following a rigorous selection and mentoring process, 6 startups emerged as winners from the final cohort of 13 accelerated ventures. On Demo Day, the selected startups were recommended for a total cumulative seed funding amounting to Rs 6 crore, with each startup receiving funding support of up to Rs 1 crore, subject to evaluation outcomes.
The shortlisted startups are Prezitech Health Pvt Ltd, (Precigo: a snap-on needle tracking system for ultrasound machines for real-time procedural planning and guidance during high precision medical interventions), Attox Research Laboratories Pvt Ltd. (AMRIT for antimicrobial resistance), Queliz Lifetech Pvt Ltd. (UltraHand, a robotic rehabilitation device), Deepfacts Private Ltd. (proRITHM is an AI-powered remote patient monitoring platform using a compact wireless, wearable device to track vitals in real time), MicroHeal and Raycura Medical Technologies (BETTER a rehabilitation device for stroke/paralysis recovery).
The gathering featured a keynote address by Dileep Mangsuli, Chairman of Cancer Treatment Services International and Senior Vice President at Siemens Healthineers, who noted, that the future of healthcare lies in delivering quality care at scale across geographies, with artificial intelligence playing a pivotal role in early screening and prevention.
